In general, MDS blasts show a CD13+CD33+CD34+ phenotype with a relatively low frequency of aberrant antigen expression, such as CD7, CD11b, and CD56 [3–5, 22]. This evidence concerns the gene CD33 and myelodysplastic syndrome.